List of Excipients in API sotagliflozin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing sotagliflozin
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Lexicon Pharmaceuticals Inc | INPEFA | sotagliflozin | 70183-220 | CROSCARMELLOSE SODIUM | 2028-05-26 |
Lexicon Pharmaceuticals Inc | INPEFA | sotagliflozin | 70183-220 | FD&C BLUE NO. 2 | 2028-05-26 |
Lexicon Pharmaceuticals Inc | INPEFA | sotagliflozin | 70183-220 | MAGNESIUM STEARATE | 2028-05-26 |
Lexicon Pharmaceuticals Inc | INPEFA | sotagliflozin | 70183-220 | MICROCRYSTALLINE CELLULOSE 102 | 2028-05-26 |
Lexicon Pharmaceuticals Inc | INPEFA | sotagliflozin | 70183-220 | MICROCRYSTALLINE CELLULOSE 200 | 2028-05-26 |
Lexicon Pharmaceuticals Inc | INPEFA | sotagliflozin | 70183-220 | POLYETHYLENE GLYCOL | 2028-05-26 |
Lexicon Pharmaceuticals Inc | INPEFA | sotagliflozin | 70183-220 | POLYVINYL ALCOHOL | 2028-05-26 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for sotagliflozin
Excipient focus: CROSCARMELLOSE SODIUM
sotagliflozin drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
>Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
sotagliflozin drug variants containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
>Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
sotagliflozin drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
>Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
sotagliflozin drug variants containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
>Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 200
sotagliflozin drug variants containing MICROCRYSTALLINE CELLULOSE 200
Company | Ingredient | NDC |
---|---|---|
Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
>Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing MICROCRYSTALLINE CELLULOSE 200
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
sotagliflozin drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
>Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
sotagliflozin drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
>Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
sotagliflozin drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
>Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
sotagliflozin drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
>Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
sotagliflozin drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
>Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.